| Net earnings | 101M |
| Impairment of assets | |
| Depreciation and amortization | 16M |
| Provision for bad debts | 6.1M |
| Stock-based compensation | 5.5M |
| Other, net | -2.2M |
| Changes in operating assets and liabilities | -13.1M |
| Net cash from operating activities | |
| Capital expenditures | -7.8M |
| Settlement of forward exchange contracts | |
| Other investing activities | -400K |
| Net cash from investing activities | |
| Net change in short-term borrowings | -47.8M |
| Repayment of debt | |
| Sale of stock and other financing activities | 400K |
| Net cash from financing activities | |
| Effect of exchange rates on cash and equivalents | 3.8M |
| Net change in cash and equivalents | |
| Cash and equivalents at beginning of period | 42.2M |
| Cash and equivalents at end of period | 27.6M |